European Journal for Philosophy of Science· 2026Q1
Industry sponsorship as meta-evidence: a simulation study
- 0citations
- Q1SCImago
- 2026year
Short summary
Simulations show that adjusting or down-weighting industry-funded research results can improve collective inquiry, but effectiveness is highly context-dependent and relies on reliable public data.
AI-generated from the title and abstract; the full text is not read.
Key points
- Industry funding can introduce systematic biases in scientific study outcomes.
- Simulations compare down-weighting industry-funded results vs. adjusting them relative to public studies.
- Both strategies are highly context-sensitive.
- Relative adjustment is effective only when public evidence is reliable and broad.
- Down-weighting requires an arbitrary choice of discount weight.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Industry funding is often indispensable to scientific research, but it can also introduce systematic biases that align study outcomes with commercial interests. Recent philosophical work suggests treating funding disclosures as meta-evidence: evidence about the evidential force of first-order study results. This paper asks whether such meta-evidence can be used to improve collective inquiry. Using an agent-based model, we compare two strategies for aggregating evidence in the presence of industry sponsorship: down-weighting industry-funded results and adjusting them relative to publicly funded studies. The simulations show that both strategies are highly context-sensitive. Relative adjustment can correct for bias when public evidence is reliable and sufficiently broad, but it falls short when public data are noisy or sparse. Down-weighting depends on a difficult and partly arbitrary choice of discount weight. The results suggest that industry sponsorship can be epistemically relevant meta-evidence without yielding a straightforward rule for evidence aggregation.
The authors' abstract, as published at the source. European Journal for Philosophy of Science, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pharmacology (Pharmacology, Toxicology and Pharmaceutics)
PharmacologyPharmacology, Toxicology and Pharmaceutics